Brodmannin

Brodmannin is a fictional or hypothetical neuropharmacological agent used in educational and theoretical contexts to illustrate concepts of targeted cortical modulation. It is not a real compound with an established chemical identity or experimental record in peer‑reviewed chemistry or pharmacology.

The name derives from Korbinian Brodmann, the German neuroscientist known for his map of the cerebral cortex into distinct areas (Brodmann areas). In these discussions, Brodmannin is imagined as a small molecule that could be delivered to specific cortical regions so as to modulate activity within a Brodmann area without broadly affecting other regions.

Conceptually, Brodmannin is described with speculative properties such as selective cortical uptake, ability to cross the blood-brain barrier, and a receptor or mechanism that yields functional specificity. In practice, no such ligand has been demonstrated, and there is no validated synthetic route or pharmacokinetic profile. The term is primarily used to foster discussion about challenges in regional brain targeting, neural circuits, and the limits of current neuropharmacology and imaging.

Because it does not correspond to an actual chemical entity, Brodmannin should not be confused with real compounds, drugs, or neuromodulators. It serves as a conceptual example in textbooks, lectures, and thought experiments about brain mapping and functional neuroanatomy.